Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease
- 1 April 1974
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 37 (4) , 422-426
- https://doi.org/10.1136/jnnp.37.4.422
Abstract
Fourteen slightly disabled patients with Parkinsonism were treated separately with benzhexol, amantadine, and levodopa. Benzhexol and amantadine both gave a 15% reduction in functional disability and levodopa a 36% reduction. Benzhexol lessened the rigidity and improved the flexion of posture of Parkinson's disease, but had little or no effect on akinesia and tremor. Amantadine and levodopa caused improvement in all these symptoms. The combination of benzhexol and amantadine was as effective after four weeks of treatment as levodopa was after six months.Keywords
This publication has 15 references indexed in Scilit:
- Treatment of Parkinson's disease with levodopa combined with L-alpha-methyldopahydrazine, an inhibitor of extracerebral DOPA decarboxylaseJournal of Neurology, Neurosurgery & Psychiatry, 1973
- Drug Therapy of ParkinsonismNew England Journal of Medicine, 1972
- Idiopathic Parkinsonism Treated with an Extracerebral Decarboxylase Inhibitor in Combination with LevodopaBMJ, 1971
- Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: A possible mode of action in Parkinson's diseaseEuropean Journal of Pharmacology, 1971
- Levodopa in Parkinsonism: the Effects of Withdrawal of Anticholinergic DrugsBMJ, 1971
- Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatmentEuropean Journal of Pharmacology, 1970
- On the mode of action of amantadineJournal of Pharmacy and Pharmacology, 1970
- AMANTADINE IN PARKINSONISMThe Lancet, 1970
- Modification of Parkinsonism — Chronic Treatment with L-DopaNew England Journal of Medicine, 1969
- Cholinergic-Anticholinergic Antagonism in ParkinsonismArchives of Neurology, 1967